Complement component C3 is not required for full expression of immune complex glomerulonephritis in MRL/lpr mice

Journal of Immunology

Volumn 166, Issue 10, 2001, Pages 6444-6451

  Sekine, Hideharu ^a   Reilly, Christopher M ^a   Molano, Ivan D ^a   Garnier, Gérard ^b   Circolo, Antonella ^c   Ruiz, Philip ^d   Holers, V Michael ^c   Boackle, Susan A ^c   Gilkeson, Gary S ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; COMPLEMENT COMPONENT C3; IMMUNOGLOBULIN G;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CROSS BREEDING; GENE DELETION; HETEROZYGOSITY; HOMOZYGOSITY; IMMUNE COMPLEX NEPHRITIS; KNOCKOUT MOUSE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA;

EID: 0035873190     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.10.6444     Document Type: Article

References (66)

1. Erdei, A., G. Füst, and J. Gergely. 1991. The role of C3 in the immune response. Immunol. Today 12:332.
2. Carroll, M. C. 1998. The role of complement and complement receptors in induction and regulation of immunity. Annu. Rev. Immunol. 16:545.
3. Schifferli, J. A., Y. C. Ng, and D. K. Peters. 1986. The role of complement and its receptor in the elimination of immune complexes. N. Engl. J. Med. 315:488.
4. Colten, H. R. 1994. Extra-hepatic complement gene expression. In New Aspects of Complement Structure and Function. A. Erdei, ed. R. G. Landes Co. Austin. TX, p. 1.
5. Ueki, A., T. Sai, H. Oka, M. Tabata, K. Hosokawa, and Y. Mochizuki. 1987. Biosynthesis and secretion of the third component of complement by human endothelial cells in vitro. Immunology 61:11.
6. Brooimans, R. A., A. P. A. Stegmann, W. T. van Dorp, A. A. J. van der Ark, F. J. van der Woude, L. A. van Es, and M. R. Daha. 1991. Interleukin 2 mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells. J. Clin. Invest. 88:379.
7. Sacks, S. H., W. Zhou, and N. S. Sheerin. 1996. Complement synthesis in the injured kidney: does it have a role in immune complex glomerulonephritis? J. Am. Soc. Nephrol. 7:2314.
8. Welch, T. R., L. S. Beischel, and D. P. Witte. 1993. Differential expression of complement C3 and C4 in the human kidney. J. Clin. Invest. 92:1451.
9. Ault, B. H., and H. R. Colten. 1994. Cellular specificity of murine renal C3 expression in two models of inflammation. Immunology 81:655.
10. Passwell, J., U. F. Schreiner, M. Nonaka, H. U. Beuscher, and H. R. Colten. 1988. Local extrahepatic expression of complement genes C3, factor B, C2 and C4 is increased in murine lupus nephritis. J. Clin. Invest. 82:1676.
11. 1) mouse strains. Immunology 71:290.
12. Sheerin, N. S., T. Springall, M. C. Carroll, B. Hartley, and S. H. Sacks. 1997. Protection against anti-glomerular basement membrane (GBM)-mediated nephritis in C3- and C4-deficient mice. Clin. Exp. Immunol. 110:403.
13. 1 mice after treatment with a blocking monoclonal antibody specific for complement component C5. Proc. Natl. Acad. Sci. USA 93:8563.
14. Walport, M. J., K. A. Davies, and M. Botto. 1998. C1q deficiencies and C1q in autoimmunity. Immunobiology 199:265.
15. Morgan, B. P., and M. J. Walport. 1991. Complement deficiency and disease. Immunol. Today 12:301.
16. Botto, M., and M. J. Walport. 1993. Hereditary deficiency of C3 in animals and humans. Int. Rev. Immunol. 10:37.
17. Nilsson, U. R., B. Nilsson, K-E. Storm, G. Sjölin-Forsberg, and R. Hällgren. 1992. Hereditary dysfunction of the third component of complement associated with a systemic lupus erythematosus-like syndrome and meningococcal meningitis. Arthritis Rheum. 35:580.
18. Peleg, D., H. Harit-Bustan, Y. Katz, S. Peller, M. Schlesinger, and S. Schonfeld. 1992. Inherited C3 deficiency and meningococcal disease in a teenager. Pediatr. Infect. Dis. J. 11:401.
19. Prodeus, A. P., S. Goerg, L-M. Shen, O. O. Pozdnyakova, L. Chu, E. M. Alicot, C. C. Goodnow, and M. C. Carroll. 1998. A critical role for complement in maintenance of self-tolerance. Immunity. 9:721.
20. Theofilopoulos, A. N., and F. J. Dixon. 1985. Murine models of systemic lupus erythematosus. Adv. Immunol 37:269.
21. Watson, M. L., J. K. Rao., G. S. Gilkeson, P. Ruiz, E. M. Eicher, D. S. Pisetsky, A. Matsuzawa, J. M. Rochelle, and M. F. Seldin. 1992. Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J. Exp. Med. 176:1645.
22. Circolo, A., G. Gamier, W. Fukuda, X. Wang, T. Hidvegi, A. J. Szalai, D. E. Briles, J. E. Volanakis, R. A. Wetsel, and H. R. Colten. 1999. Genetic disruption of the murine complement C3 promoter region generates deficient mice with extrahepatic expression of C3 mRNA. Immunopharmacology 42:135.
23. Peng, S. L., and J. Craft. 1996. PCR-RFLP genotyping of murine MHC haplotypes. BioTechniques 21:362.
24. Gilkeson, G. S., J. Grudier, D. Karounos, and D. Pisetsky. 1989. Induction of anti-dsDNA antibodies in normal mice by immunization with bacterial DNA. J. Immunol. 142:1482.
25. Bernstein, K. A., R. D. Valerio, and J. B. Lefkowith. 1995. Glomerular binding activity in MRL lpr serum consists of antibodies that bind to a DNA/histone/type IV collagen complex. J. Immunol. 154:2424.
26. Abdelmoula, M., F. Spertini, T. Shibata, Y. Gyotoku, S. Luzuy, P.-H. Lambert, and S. Izui. 1989. IgG3 is the major source of cryoglobulins in mice. J. Immunol. 143:526.
27. Toth, C. A., D. Pohl, and Y. Agnello. 1986. Methods for detection of immune complexes by utilizing C1q or rheumatoid factors. In Manual of Clinical Laboratory Immunology. N. R. Rose, H. Friedman, and J. L. Fahey, eds. American Society for Microbiology, Washington, DC, p. 204.
28. Fulpius, T., F. Spertini, L. Reininger, and S. Izui. 1993. Immunoglobulin heavy chain constant region determines the pathogenicity and the antigen-binding activity of rheumatoid factor. Proc. Natl. Acad. Sci. USA 90:2345.
29. Nose, M., M. Nishimura, M. R. Ito, J. Itoh, T. Shibata, and T. Sugisaki. 1996. Arteritis in a novel congenic strain of mice derived from MRL/lpr lupus mice: genetic dissociation from glomerulonephritis and limited autoantibody production. Am. J. Pathol. 149:1763.
30. Molina, H., M. V. Holers, B. Li, Y. Fung, S. Mariathasan, J. Goellner, J. Strauss-Schoenberger, W. R. Karr, and D. D. Chaplin. 1996. Markedly impaired humoral immune response in mice deficient in complement receptor 1 and 2. Proc. Natl. Acad. Sci. USA 93:3357.
31. Ahearn, J. M., M. B. Fischer, D. Croix, S. Goerg, M. Ma, J. Xia, X. Zhou, R. G. Howard, T. L. Rothstein, and M. C. Carroll. 1996. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity 4:251.
32. Lemoine, R., T. Bemey, T. Shibata, T. Fulpius, Y. Gyotoku, H. Shimada, S. Sawada, and S. Izui. 1992. Induction of "wire-loop" lesions by murine monoclonal IgG3 cryoglobulins. Kidney Int. 41:65.
33. Fulpius, T., R. Lemoine, T. Berney, Y. Pastore, S. Moll, and S. Izui. 1996. Polymorphonuclear leukocytes play a key role in the generation of "wire-loop" lesions induced by a murine IgG3 rheumatoid factor. Kidney Int. 49:647.
34. + T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis. J. Immunol. 143:103.
35. Ficher, M. B., M. Ma, S. Goerg, X. Zhou, J. Xia, O. Finco, S. Han, G. Kelsoe, R. G. Howard, T. L. Rothstein, E. Kremmer, F. S. Rosen, and M. C. Carroll. 1996. Regulation of the B cell response to T-dependent antigens by classical pathway complement. J. Immunol. 157:549.
36. Watanabe, H., G. Gamier, A. Circolo, R. A. Westel, P. Ruiz, V. M. Holers, S. A. Boackle, H. R. Colten, and G. S. Gilkeson. 2000. Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B. J. Immunol. 164:786.
37. Schifferli, J. A., and R. P. Taylor. 1989. Physiological and pathological aspects of circulating immune complexes. Kidney Int. 35:993.
38. Sawtell, N. M., A. L. Hartman, M. A. Weiss, A. J. Pesce, and J. G. Michael. 1988. C3 dependent, C5 independent immune complex glomerulopathy in the mouse. Lab. Invest. 58:287.
39. Mitchell, D. A., P. R. Taylor, H. T. Cook, J. Moss, A. E. Bygrave, M. J. Walport, M. Botto. 1999. C1q protects against the development of glomerulonephritis independently of C3 activation. J. Immunol. 162:5676.
40. Quigg, R. J., J. J. Alexander, C. F. Lo, A. Lim, C. He, and V. M. Holers. 1997. Characterization of C3-binding proteins on mouse neutrophils and platelets. J. Immunol. 159:2438.
41. Fujigaki, Y., M. Nagase, and N. Honda. 1993. Intraglomerular basement membrane translocation of immune complex (IC) in the development of passive in situ IC nephritis of rats. Am. J. Pathol. 142:831.
42. Fujigaki, Y., S. R. Batsford, D. Bitter-Suermann, and A. Vogt. 1995. Complement system promotes transfer of immune complex across glomerular filtration barrier. Lab. Invest. 72:25.
43. Sheerin, N. S., T. Springall, M. Carroll, and S. H. Sacks. 1999. Altered distribution of intraglomerular immune complexes in C3-deficient mice. Immunology 97:393.
44. Nangaku, M. 1998. Complement regulatory proteins in glomerular disease. Kidney Int. 54:1419.
45. Quigg, R. J., V. M. Holers, B. P. Morgan, and A. E. Sneed III. 1995. Crry and CD59 regulate complement in rat glomerular epithelial cells and are inhibited by the nephritogenic antibody of passive Heymann nephritis. J. Immunol. 154:3437.
46. Quigg, R. J., B. P. Morgan, V. M. Holers, S. Adler, A. E. Sneed III, and C. F. Lo. 1995. Complement regulation in the rat glomerulus: Crry and CD59 regulate complement in glomerular mesangial and endothelial cells. Kidney. Int. 48:412.
47. Cosio, F. G., D. D. Sedmak, J. D. Mahan, and N. S. Nahman, Jr 1989. Localization of decay accelerating factor in normal and diseased kidneys. Kidney Int. 36:100.
48. Cosio, F. G., T. Shibata, B. H. Rovin, and D. J. Birmingham. 1994. Effects of complement activation products on the synthesis of decay accelerating factor and membrane cofactor protein by human mesangial cells. Kidney Int. 46:986.
49. Shibata, T., and T. Kohsaka. 1995. Effects of complement activation on the expression of CD59 by human mesangial cells. J. Immunol. 155:403.
50. Moutabarrik, A., I. Nakanishi, M. Matsumoto, D. Zaid, and T. Seya. 1995. Human glomerular epithelial cells synthesize and secrete the third component of complement. Nephron 70:55.
51. Tamai, H., S. Matsuo, A. Fukatsu, K. Nishikawa, N. Sakamoto, K. Yoshida, N. Okada, and H. Okada. 1991. Localization of 20-kD homologous restriction factor (HRF20) in diseased human glomeruli. An immunofluorescence study. Clin. Exp. Immunol. 84:256.
52. Abe, K., M. Miyazaki, T. Koji, A. Furusu, Y. Ozono, T. Harada, H. Sakai, P. K. Nakane, and S. Kohno. 1998. Expression of decay accelerating factor mRNA and complement C3 mRNA in human diseased kidney. Kidney Int. 54: 120.
53. Quigg, R. J., C. He, A. Lim, D. Berthiaume, J. J. Alexander, D. Kraus, and V. M. Holers. 1998. Transgenic mice overexpressing the complement inhibitor Crry as a soluble protein are protected from antibody-induced glomerular injury. J. Exp. Med. 188:1321.
54. Quigg, R. J., Y. Kozono, D. Berthiaume, A. Lim, D. J. Salant, A. Weinfeld, P. Griffin, E. Kremmer, and V. M. Holers. 1998. Blockade of antibody-induced glomerulonephritis with Crry-Ig, a soluble murine complement inhibitor. J. Immunol. 160:4553.
55. Sakai, T., and W. Kriz. 1987. The structural relationship between mesangial cells and basement membrane of the renal glomerulus. Anat. Embryol. 176:373.
56. Sedor, J. R., S. W. Carey, and S. N. Emancipator. 1987. Immune complexes bind to cultured rat glomerular mesangial cells to stimulate superoxide release: evidence for an Fc receptor. J. Immunol. 138:3751.
57. Santiago, A., J. Satriano, S. DeCandido, H. Holthofer, R. Scheriber, J. Unkeless, and D. Schlondorff. 1989. A specific Fcγ receptor on cultured rat mesangial cells. J. Immunol. 143:2575.
58. Morcos, M., G. M. Mänsch, M. Schönermark, S. Ellwanger, M. Härle, and B. Heckl-Östreicher. 1994. Human glomerular mesangial cells express CD16 and may be stimulated via this receptor. Kidney Int. 46:1627.
59. Ooi, B. S., D. J. Cohen, and J. H. Veis. 1996. Biology of the mesangial cell in glomerulonephritis: role of cytokines. Proc. Soc. Exp. Biol. Med. 213:230.
60. 2 and proliferator activation receptor-γ agonists. J. Immunol. 164:1498.
61. 2 and platelet-activating factor formation by cultured mesangial cells. J. Clin. Invest. 82:936.
62. Knauss, T. C., P. Mené, S. A. Ricanati, M. Kester, G. R. Dubyak, S. N. Emancipator, and J. R. Sedor. 1989. Immune complex activation of rat glomerular mesangial cells: dependence on Fc region of antibody. Am. J. Physiol. 257:F478.
63. Hora, K., J. A. Satriano, A. Santiago, T. Mori, E. R. Stanley, Z. Shan, and D. Schlondorff. 1992. Receptors for IgG complexes activate synthesis of monocyte chemoattractant peptide 1 and colony-stimulating factor 1. Proc. Natl. Acad. Sci. USA 89:1745.
64. van den Dobbelsteen, M. E. A., F. J. van der Woude, W. E. M. Schroeijers, L. A. van Es, and M. R. Daha. 1993. Soluble aggregates of IgG and immune complexes enhance IL-6 production by renal mesangial cells. Kidney Int. 43:544.
65. Lopez-Armada, M. J., C. Gómez-Guerrero, and J. Egido. 1996. Receptors for immune complexes activate gene expression and synthesis of matrix proteins in cultured rat and human mesangial cells: role of TGF-β. J. Immunol. 157:2136.
66. Clynes, R., C. Dumitru, and J. V. Ravetch. 1998. Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 279:1052.